Company Filing History:
Years Active: 1990
Title: Keiko Nogata: Innovator in Triglyceride Analysis
Introduction
Keiko Nogata, a talented inventor based in Shizuoka, Japan, has made significant contributions to the field of biochemistry. With her innovative research, she has developed a unique DNA sequence that plays a crucial role in the quantitative analysis of triglycerides and glycerine. Her passion for science and commitment to innovation exemplify the spirit of modern inventors.
Latest Patents
Keiko Nogata holds one notable patent that focuses on DNA encoding for L-alpha-glycerophosphate oxidase (GPO). This patent describes a DNA sequence that contains genetic information essential for producing a polypeptide composed of a specified amino acid sequence, which constitutes GPO. By inserting this DNA into a plasmid and culturing the transformant in selected host microorganisms such as Escherichia coli, Bacillus subtilis, or Saccharomyces cerevisiae, the polypeptide can be effectively produced. The GPO enzyme is instrumental in the quantitative analysis of triglyceride levels, glycerine, and in determining lipase activity, especially when used in conjunction with other enzymes.
Career Highlights
Currently, Keiko Nogata is employed at Toyo Jozo Company, Ltd., where she applies her scientific knowledge to further innovations in biochemistry and enzymology. Her work contributes to the understanding of enzyme functions and applications in various fields, including medical and food industries.
Collaborations
Throughout her career, Keiko has collaborated with fellow researchers, including Hitoshi Sagai and Mamoru Takahashi. These partnerships have fostered innovation and accelerated research developments in their projects, showcasing the importance of teamwork in scientific discoveries.
Conclusion
Keiko Nogata's work underscores the impact of innovative research in the analysis of biochemical substances. Her patent on GPO represents a significant advancement in the field, aiding in the accurate measurement of essential biological compounds. Keiko’s dedication to her field and her collaborations with esteemed colleagues positions her as a key figure in advancing biochemistry and related technologies.